Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)

PHASE3CompletedINTERVENTIONAL
Enrollment

5,407

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Deep Vein ThrombosisPulmonary Embolism
Interventions
DRUG

Enoxaparin

Subcutaneous, 40 mg, once daily, 5 weeks

DRUG

Apixaban

Oral tablets, 2.5 mg, twice daily, 5weeks

DRUG

Enoxaparin-matching placebo

Administered as injection

DRUG

Apixaban-matching placebo

Administered as oral tablets

Trial Locations (143)

1081

Local Institution, Budapest

1346

Local Institution, Gjettum

2000

Local Institution, Frederiksberg

2020

Local Institution, Antwerp

2050

Local Institution, Camperdown

2212

Local Institution, Kongsvinger

2217

Local Institution, Kogarah

2300

Local Institution, Amager

2400

Local Institution, København NV

2480

Local Institution, Lismore

2500

Local Institution, Tynset

2629

Local Institution, Lillehammer

2650

Local Institution, Hvidovre

2730

Local Institution, Herlev

2930

Local Institution, Brasschaat

2970

Local Institution, Hørsholm

3000

Local Institution, Leuven

3116

Local Institution, Tønsberg

3128

Local Institution, Box Hill

3144

Local Institution, Malvern

3181

Local Institution, Windsor

3500

Local Institution, Hasselt

3600

Local Institution, Genk

4215

Local Institution, Southport

5000

Local Institution, Szolnok

5042

Local Institution, Bedford Park

6000

Local Institution, Perth

Local Institution, Kecskemét

6720

Local Institution, Szeged

8600

Local Institution, Silkeborg

16602

University Orthopedic Center, Altoona

18009

Local Institution, Cherkassy

20010

Local Institution, Aguascalientes

22010

Local Institution, Tijuana

30033

Atlanta Knee And Sports Medicine, Decatur

31020

Local Institution, Chihuahua City

31096

Local Institution, Haifa

33316

Shrock Orthopedic Research, Fort Lauderdale

33321

Phoenix Clinical Research, Llc, Tamarac

33511

Pab Clinical Research, Brandon

33756

Research Alliance, Inc., Clearwater

35209

Capstone Clinical Trials, Inc, Birmingham

West Alabama Research, Llc, Birmingham

42100

Local Institution, Saint-Etienne

44281

Local Institution, Kfar Saba

45235

Local Institution, Guadalajara

49005

Local Institution, Dnipropetrovsk

58013

Local Institution, Chernivtsy

58100

Local Institution, Holon

59880

Local Institution, Saint-Saulve

60528

Local Institution, Frankfurt

64460

Local Institution, Monterrey

65929

Local Institution, Frankfurt am Main

70300

Local Institution, Ẕerifin

72205

Martin Bowen Hefley Orthopedics, Little Rock

Orthoarkansas, P.A., Little Rock

75014

Local Institution, Paris

75019

Local Institution, Paris

75679

Local Institution, Paris

76008

Local Institution, Ivano-Frankivsk

78217

Unlimited Research, San Antonio

79410

Gill Orthopedic Center, Lubbock

Robert R. King, Md, Lubbock

79618

Local Institution, Rheinfelden

80012

Colorado Orthopedic Consultants, Pc, Aurora

80230

Advanced Orthopedic And Sports Medicine Specilists, Denver

Denver-Vail Orthopedics, P.C., Denver

83642

Bosie Orthopedic Clinic, Meridian

83702

Americana Orthopedics, Boise

84101

Local Institution, Beersheba

89240

Local Institution, Ciudad Madero

95817

Uc Davis Medical Center, Sacramento

99018

Local Institution, Sevastopol

100035

Local Institution, Beijing

100853

Local Institution, Beijing

111539

Local Institution, Moscow

115522

Local Institution, Moscow

117292

Local Institution, Moscow

119415

Local Institution, Moscow

141001

Local Institution, Ludhiana

150003

Local Institution, Yaroslavl

192242

Local Institution, Saint Petersburg

193312

Local Institution, Saint Petersburg

194354

Local Institution, Saint Petersburg

195427

Local Institution, Saint Petersburg

196247

Local Institution, Saint Petersburg

199106

Local Institution, Saint Petersburg

200011

Local Institution, Shanghai

200025

Local Institution, Shanghai

200233

Local Institution, Shanghai

226003

Local Institution, Lucknow

266003

Local Institution, Qingdao

380015

Local Institution, Ahmedabad

400132

Local Institution, Cluj-Napoca

420029

Local Institution, Kazan'

443095

Local Institution, Samara

454021

Local Institution, Chelyabinsk

510405

Local Institution, Guangzhou

560034

Local Institution, Bangalore

575001

Local Institution, Mangalore

C1199ACK

Local Institution, Capital Federal

C1280AEB

Local Institution, Capital Federal

C1425AGP

Local Institution, Capital Federal

C1426BOS

Local Institution, Ciudad de Buenos Aires

B7540GHD

Local Institution, Coronel Suárez

B1842DID

Local Institution, Monte Grande

T6G 2B7

Local Institution, Edmonton

L1S 2J5

Local Institution, Ajax

N1R 7L7

Local Institution, Cambridge

N7L 4T1

Local Institution, Chatham

N1E 6L9

Local Institution, Guelph

L3Y 5G8

Local Institution, Newmarket

L1J 2J2

Local Institution, Oshawa

N7T 6H3

Local Institution, Sarnia

M1S 4T7

Local Institution, Scarborough Village

L2R 7P3

Local Institution, St. Catharines

N5A 2N4

Local Institution, Stratford

N2J 1C4

Local Institution, Waterloo

N8W 1E6

Local Institution, Windsor

H3G 1A4

Local Institution, Montreal

G1L 3L5

Local Institution, Québec

06200

Local Institution, Nice

06726

Local Institution, Mexico City

07760

Local Institution, Mexico City

80-803

Local Institution, Gdansk

91-002

Local Institution, Lodz

71-252

Local Institution, Szczecin

02-005

Local Institution, Warsaw

03-242

Local Institution, Warsaw

50-556

Local Institution, Wroclaw

021659

Local Institution, Bucharest

08916

Local Institution, Badalona-Barcelone

08006

Local Institution, Barcelona

08024

Local Institution, Barcelona

08035

Local Institution, Barcelona

08036

Local Institution, Barcelona

416 85

Local Institution, Gothenburg

182 88

Local Institution, Stockholm

01601

Local Institution, Kyiv

04107

Local Institution, Kyiv

SE5 9RS

Local Institution, London

WN6 9EP

Local Institution, Wigan

KT18 7EG

Local Institution, Epsom

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT00423319 - Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3) | Biotech Hunter | Biotech Hunter